Literature DB >> 10192348

Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients.

G Marshak1, B Brenner, J Shvero, J Shapira, D Ophir, I Hochman, G Marshak1, A Sulkes, E Rakowsky.   

Abstract

PURPOSE: Different radiation therapy schedules and devices have been used over the last 20 years at Rabin Medical Center in patients with early glottic cancer. The aim of the present retrospective analysis was to identify the subgroup of patients at high risk of failure of radiation treatment.
MATERIALS AND METHODS: Between 1974 and 1994, 207 patients with squamous cell carcinoma of the glottis, 182 Stage T1 and 25 Stage T2, underwent definitive radiation therapy. During this period, treatment was administered with different radiation devices (60Co or 6-MV X ray), using different dose/fraction protocols (1.8 or 2 Gy per day, 5 or 6 fractions per week), total doses (42-77.4 Gy), overall radiation times, and delays. These treatment variables, in addition to certain patient and tumor characteristics, were correlated with local control at a median follow-up of 57 months (range 18-265 months).
RESULTS: The 5-year local control rates for T1 and T2 tumors were 88% and 73%, respectively. Univariate analysis showed that smoking, diabetes mellitus, anterior commissure involvement, T stage, and extension of tumor to one third or more of the vocal cord were highly significantly correlated with decreased local control. None of the treatment variables, including dosage at which complete tumor regression was noted, were found to be predictive. By multivariate analysis, only anterior commissure involvement was found to be highly significant (risk ratio 1.9, 95% CI 1.2-3.0, p = 0.027), and T stage was borderline significant (risk ratio 1.6, 95% CI 1.0-2.5, p = 0.054).
CONCLUSION: This study suggests that only two tumor characteristics are predictive of local failure of early glottic cancer: anterior commissure involvement and T stage. Treatment variables apparently do not influence local control.

Entities:  

Mesh:

Year:  1999        PMID: 10192348     DOI: 10.1016/s0360-3016(98)00547-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  26 in total

1.  Treatment and predictive factors in patients with recurrent laryngeal carcinoma: A retrospective study.

Authors:  Peijing Li; Weihan Hu; Yuan Zhu; Jianjiang Liu
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

2.  Management of the N0 neck in recurrent laryngeal squamous cell carcinoma.

Authors:  Pei-Jing Li; Wei-Han Hu; Ting Jin
Journal:  Mol Clin Oncol       Date:  2015-10-29

3.  [Glottic laryngeal carcinoma. Tis, T1 and T2--long term results after laser resection].

Authors:  O König; U Bockmühl; K Haake
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

4.  Outcome of radiotherapy in T1 glottic carcinoma: a population-based study.

Authors:  Elisabeth Victoria Sjögren; Ruud G J Wiggenraad; Saskia Le Cessie; Simone Snijder; Jaqueline Pomp; Robert Jan Baatenburg de Jong
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-07       Impact factor: 2.503

5.  Diagnosis of anterior commissure invasion in laryngeal cancer.

Authors:  Baris Naiboglu; Vefa Kinis; Sema Zer Toros; Tulay Erden Habesoglu; Ildem Deveci; Mehmet Surmeli; Erol Egeli
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-13       Impact factor: 2.503

6.  T1-2 glottic cancer treated with radiotherapy and/or surgery.

Authors:  Mohamed Shelan; Lukas Anschuetz; Adrian D Schubert; Beat Bojaxhiu; Alan Dal Pra; Frank Behrensmeier; Daniel M Aebersold; Roland Giger; Olgun Elicin
Journal:  Strahlenther Onkol       Date:  2017-05-04       Impact factor: 3.621

7.  Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.

Authors:  Yosuke Kitani; Akira Kubota; Madoka Furukawa; Kaname Sato
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-01       Impact factor: 2.503

8.  Supracricoid partial laryngectomy cricohyoidoepiglottopexy (SCPL-CHEP) versus vertical partial laryngectomy for the treatment of glottic carcinoma.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Liang-Si Chen; Xiao-Ning Luo; Ping-Jiang Ge; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-16       Impact factor: 2.503

9.  Prospective analysis of functional swallowing outcome after resection of T2 glottic carcinoma using transoral laser surgery and external vertical hemilaryngectomy.

Authors:  Hani Osama Nasef; Hossam Thabet; Cesare Piazza; Francesca Del Bon; Mohamed Eid; Manal El Banna; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-27       Impact factor: 2.503

10.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer.

Authors:  Yoshiyuki Itoh; Nobukazu Fuwa
Journal:  Radiat Med       Date:  2006-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.